CDIO
Cardio Diagnostics Holdings Inc
NASDAQ: CDIO · HEALTHCARE · BIOTECHNOLOGY
$1.70
-1.16% today
Updated 2026-04-29
Market cap
$5.39M
P/E ratio
—
P/S ratio
363.32x
EPS (TTM)
$-3.71
Dividend yield
—
52W range
$1 – $14
Volume
4.2M
Cardio Diagnostics Holdings Inc (CDIO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-41,160.00%
ROE
-78.60%
ROA
-44.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | $0.00 | $-605164.00 | — | — | — |
| 2021 | $901.00 | $-620448.00 | 100.00% | -68,862.15% | -68,862.15% |
| 2022 | $950.00 | $-4.66M | 100.00% | -478,784.32% | -490,630.00% |
| 2023 | $17065.00 | $-8.38M | 100.00% | -42,440.43% | -49,087.81% |
| 2024 | $34890.00 | $-8.38M | 100.00% | -23,977.86% | -24,028.24% |
| 2025 | $14825.00 | $-6.50M | -2,585.52% | -43,737.46% | -43,832.49% |